Innovar-Vet Inj 20 mg Solution is a Health Canada–registered veterinary drug (DIN 00755672) held by Janssen, containing Droperidol. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2004). Nexara Health has matched 49 registrations of Droperidol across 17 other regulated markets.
Health Canada registration
| DIN | 00755672 |
|---|---|
| Brand name | Innovar-Vet Inj |
| Active ingredient | Droperidol |
| Strength | 20 mg |
| Dosage form | Solution |
| Route | Intramuscular ; Intravenous |
| Company | Janssen |
| Status | Cancelled Post Market — 04 Aug 2004 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Droperidol registered in other markets
49 registrations of the same molecule in 17 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Bolivia | Droperidol | — | 2,5 mg/ml | Inyectable | LINAME (formulary) | |
| Brazil | Droperdal | Cristália Produtos Químicos Farmacêuticos Ltda. | 2,5 MG/ML SOL INJ IM/IV CX 50 AMP VD AMB X 1 ML | Similar | CMED | |
| Brazil | Droperdal | Cristália Produtos Químicos Farmacêuticos Ltda. | 2,5 MG/ML SOL INJ IM/IV CX 25 AMP VD AMB X 1 ML | Similar | CMED | |
| Denmark | Dehydrobenzperidol | Substipharm | 2,5 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Droperidol "Aguettant" | Laboratoire Aguettant | 1,25 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Droperidol "Aguettant" | Laboratoire Aguettant | 2,5 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Droperidol "Sintetica" | Sintetica GmbH | 0,5 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Dominican Republic | Droperidol | Laboratorio Sanderson, S.a. | Registered | MISPAS | ||
| Finland | Dehydrobenzperidol | ProStrakan Ltd. | 2.5 mg/ml | injektioneste, liuos | Myyntilupa peruuntunut | Fimea Perusrekisteri |
| Finland | Dehydrobenzperidol | Substipharm | 2.5 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Droperidol Aguettant | Laboratoire Aguettant | 2.5 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Droperidol Aguettant | Laboratoire Aguettant | 1.25 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Finland | Droperidol Sintetica | Sintetica GmbH | 0.5 mg/ml | injektioneste, liuos | Myyntilupa myönnetty | Fimea Perusrekisteri |
| Greece | XOMOLIX INJ.SOL 2,5MG/ML BTx 10 AMPS x 1 ML (σε γυάλινη φύσιγγα) (σε γυάλινη φύσιγγα) | Substipharm, France | reimbursed | MoH deltio timwn | ||
| Iceland | Dridol | Parlogis - óskráð lyf | 2,5 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Iceland | Droperidol | Parlogis - óskráð lyf | 2,5 mg/ml | stl | 0 | Lyfjastofnun lyfjaverdskra |
| Ireland | Droperidol 0.5 mg/ml solution for injection | Sintetica GmbH | Solution for injection | Not marketed | HPRA | |
| Ireland | Droperidol 1.25 mg/ml solution for injection | Laboratoire Aguettant | Solution for injection | Not marketed | HPRA | |
| Ireland | Droperidol 2.5 mg/ml solution for injection | Laboratoire Aguettant | Solution for injection | Not marketed | HPRA | |
| Jordan | Droperidol Sintetica 1 mg/2ml Solution for Injection | Sintetica SA | 0.5 MG/1 ML | Solution for injection | NEW APPLICATION | JFDA drug registrations |
| Netherlands | Dehydrobenzperidol 0,5 mg/ml oplossing voor injectie | Substipharm | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Dehydrobenzperidol IV oplossing voor intraveneuze injectie 2,5 mg/ml, oplossing voor injectie | Substipharm | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Droperidol Aguettant 2,5 mg/ml oplossing voor injectie | Laboratoire Aguettant | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Droperidol Hikma 2,5 mg/ml oplossing voor injectie | Hikma Farmaceutica (Portugal), S.A. | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Droperidol Kalceks 1,25 mg/ml oplossing voor injectie | AS Kalceks | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Netherlands | Droperidol Kalceks 2,5 mg/ml oplossing voor injectie | AS Kalceks | Oplossing voor injectie | Uitsluitend recept | EU national register | |
| Norway | Dridol inj, oppl 2,5 mg/ml | Substipharm | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Droperidol arrow inj, oppl 2,5 mg/ml | Arrow | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Droperidol hikma inj, oppl 2,5 mg/ml | Hikma | 10 x 1 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Norway | Droperidol Sintetica inj, oppl 0,5 mg/ml | Sintetica GmbH | 10 x 2.5 | Injeksjonsvæske, oppløsning | Aktiv oppføring | FEST (DMP) |
| Romania | DROPERIDOL AGUETTANT 2,5 mg/ml | — | 2,5mg/ml | Sol Inj. | PR | ANMDMR nomenclator |
| Romania | DROPERIDOL KALCEKS 2,5 mg/ml | — | 2,5mg/ml | Sol Inj. | PR | ANMDMR nomenclator |
| Saudi Arabia | Doravit 1.25mg/mL I.v. Injection | — | 1.25 | Inactive | SFDA | |
| South Africa | Droperidol Equity | Equity Pharmaceuticals (Pty) Ltd | 1.25 mg/ml | Inj | S5 | DoH SEP database |
| South Africa | Inapsin | MC Pharma (Pty) Ltd | mg/ml | Inj | S5 | DoH SEP database |
| Taiwan | Dehydrobenzperidol | Janssen Pharmaceutica N.v. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Dehydrobenzperidol | Janssen Pharmaceutica N.v. | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Dropedol Injection 2.5mg/mL | 聯亞藥業股份有限公司新竹廠 | 注射劑 | Registered | TFDA | |
| Taiwan | Dropel Injection 2.5mg/mL | 壽元化學工業股份有限公司 | 注射劑 | Registered | TFDA | |
| United Kingdom | Droperidol 1mg capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Droperidol 2.5mg/1ml solution for injection ampoules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Droperidol 2.5mg/1ml solution for injection vials | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Droperidol 500microgram capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Droperidol 5mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Droperidol 5mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United States | Droperidol | Hikma Pharmaceuticals USA Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Droperidol | Hikma Pharmaceuticals USA Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Droperidol | American Regent, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Droperidol | GRINDEKS Joint Stock Company | Powder | FDA NDC |
See every manufacturer of Droperidol worldwide →
Regulator price references for Droperidol
Published list or reimbursement prices for Droperidol presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Brazil | Droperdal | 2.5mg/1ml | 2,5 MG/ML SOL INJ IM/IV CX 25 AMP VD AMB X 1 ML | 248.69 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Brazil | Droperdal | 2.5mg/1ml | 2,5 MG/ML SOL INJ IM/IV CX 50 AMP VD AMB X 1 ML | 496.38 BRL | preco fabrica (ex-factory ceiling) | CMED | 2026-09-02 |
| Greece | XOMOLIX INJ.SOL 2,5MG/ML BTx 10 AMPS x 1 ML (σε γυάλινη φύσιγγα) (σε γυάλινη φύσιγγα) | 2.5mg/1ml | 23.47 EUR | producer price (ex-factory) | MoH deltio timwn | 2026-09-03 | |
| Iceland | Dridol | 2.5mg/1ml | lykjur | 6,002.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Iceland | Droperidol | 2.5mg/1ml | lykjur | 13,658.00 ISK | max wholesale | Lyfjastofnun lyfjaverdskra | 2026-09-02 |
| Norway | Dridol | 2.5mg/1ml | 1 ml | 396.20 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Norway | Droperidol Sintetica | 0.5mg/1ml | 2.5 ml | 660.50 NOK | max AUP (pharmacy retail) | DMP (Statens legemiddelverk) maksimalpris | 2026-09-07 |
| Saudi Arabia | Doravit 1.25mg/mL I.v. Injection | 1.25mg/1ml | 188.20 SAR | public | SFDA | 2026-09-01 | |
| South Africa | Droperidol Equity | 1.25mg/1ml | 1 | 408.00 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Inapsin | 2 | 486.24 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Innovar-Vet Inj (DIN 00755672) marketed in Canada?
No. Health Canada lists DIN 00755672 as Cancelled Post Market as of 04 Aug 2004.
Who holds the Canadian licence for this product?
Janssen is the company of record in the Health Canada Drug Product Database.
Is Droperidol registered outside Canada?
Yes — Nexara Health has matched 49 registrations in 17 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00755672, status date 2004-08-04; national medicine registries: ANMDMR nomenclator, CMED, DoH SEP database, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, NHS dm+d VMP, SFDA, TFDA; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00755672, status date 2004-08-04; national medicine registries: ANMDMR nomenclator, CMED, DoH SEP database, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, NHS dm+d VMP, SFDA, TFDA; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA.
Health Canada Drug Product Database (DPD), DIN 00755672, status date 2004-08-04; national medicine registries: ANMDMR nomenclator, CMED, DoH SEP database, EU national register, FDA NDC, FEST (DMP), Fimea Perusrekisteri, HPRA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Lyfjastofnun lyfjaverdskra, MISPAS, MoH deltio timwn, NHS dm+d VMP, SFDA, TFDA; price sources: CMED, DMP (Statens legemiddelverk) maksimalpris, DoH SEP database, Lyfjastofnun lyfjaverdskra, MoH deltio timwn, SFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.